Drug details:
Molecular formula: C₂₄H₂₉BrO₁₁

Standard name: [3,4,5-triacetyloxy-6-[(R)-acetyloxy-(4-bromo-2-methylphenyl)methyl]oxan-2-yl]methyl acetate

Curated SMILES: CC(=O)OCC1OC([C@H](OC(C)=O)C2=C(C)C=C(Br)C=C2)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O

Evidence for compound's anti-virulence activity:

Escherichia
Related VF: Type 1 fimbriae
Target: FimH
Drug effect: Bound to the FimH lectin domain to interfere with bacterial adhesion, invasion and biofilm formation.
Max phase: Preclinical (in vivo)
Publication:
Mydock-McGrane L, et al., 2016. Antivirulence C-Mannosides as Antibiotic-Sparing, Oral Therapeutics for Urinary Tract Infections. J Med Chem 59(20):9390-9408.